ATAI vs. DCTH
ATAI (Atai Life Sciences N.V.) and DCTH (Delcath Systems, Inc.) are both stocks. Both are in the Healthcare sector — ATAI in Biotechnology, DCTH in Medical Devices. Over the past 3 years, ATAI returned 35.22%/yr vs 17.10%/yr for DCTH. At a 0.22 correlation, their price movements are largely independent.
Performance
ATAI vs. DCTH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATAI achieves a 10.02% return, which is significantly higher than DCTH's 6.83% return.
ATAI
- 1D
- -0.66%
- 1M
- 12.50%
- YTD
- 10.02%
- 6M
- 2.27%
- 1Y
- 82.19%
- 3Y*
- 35.22%
- 5Y*
- —
- 10Y*
- —
DCTH
- 1D
- 4.45%
- 1M
- -6.42%
- YTD
- 6.83%
- 6M
- 7.68%
- 1Y
- -34.13%
- 3Y*
- 17.10%
- 5Y*
- 0.06%
- 10Y*
- —
ATAI vs. DCTH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ATAI Atai Life Sciences N.V. | 10.02% | 207.52% | -5.67% | -46.99% | -65.14% | -60.77% |
DCTH Delcath Systems, Inc. | 6.83% | -16.11% | 189.42% | 15.56% | -53.55% | -23.95% |
Correlation
The correlation between ATAI and DCTH is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jun 21, 2021 | 0.22 |
Fundamentals
ATAI:
$1.61B
DCTH:
$388.67M
ATAI:
-$2.67
DCTH:
$0.01
ATAI:
320.49
DCTH:
6.30
ATAI:
8.10
DCTH:
3.45
ATAI:
$3.49M
DCTH:
$65.45M
ATAI:
$3.49M
DCTH:
$77.75M
ATAI:
-$663.38M
DCTH:
$222.00K
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATAI vs. DCTH — Risk / Return Rank
ATAI
DCTH
ATAI vs. DCTH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and Delcath Systems, Inc. (DCTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ATAI | DCTH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.73 | ||
| Sortino ratioReturn per unit of downside risk | +2.78 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 0.90 | +0.33 |
| Calmar ratioReturn relative to maximum drawdown | 1.72 | -0.67 | +2.38 |
| Martin ratioReturn relative to average drawdown | 2.79 | -0.91 | +3.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ATAI | DCTH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.03 | -0.70 | +1.73 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.00 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.31 | -0.44 | +0.13 |
Drawdowns
ATAI vs. DCTH - Drawdown Comparison
The maximum ATAI drawdown since its inception was -94.77%, smaller than the maximum DCTH drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for ATAI and DCTH.
Loading charts...
Drawdown Indicators
| ATAI | DCTH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.77% | -99.96% | +5.19% |
Max Drawdown (1Y)Largest decline over 1 year | -48.06% | -51.45% | +3.39% |
Max Drawdown (3Y)Largest decline over 3 years | -59.23% | -68.97% | +9.74% |
Max Drawdown (5Y)Largest decline over 5 years | — | -82.21% | — |
Current DrawdownCurrent decline from peak | -77.38% | -99.82% | +22.44% |
Average DrawdownAverage peak-to-trough decline | -79.77% | -96.46% | +16.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.52% | 37.69% | -8.17% |
Volatility
ATAI vs. DCTH - Volatility Comparison
Atai Life Sciences N.V. (ATAI) has a higher volatility of 15.38% compared to Delcath Systems, Inc. (DCTH) at 10.97%. This indicates that ATAI's price experiences larger fluctuations and is considered to be riskier than DCTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATAI | DCTH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.38% | 10.97% | +4.41% |
Volatility (6M)Calculated over the trailing 6-month period | 49.13% | 31.86% | +17.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.43% | 49.10% | +31.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.66% | 73.08% | +10.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.66% | 110.12% | -26.46% |
Dividends
ATAI vs. DCTH - Dividend Comparison
Neither ATAI nor DCTH has paid dividends to shareholders.
Financials
ATAI vs. DCTH - Financials Comparison
This section allows you to compare key financial metrics between Atai Life Sciences N.V. and Delcath Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATAI and DCTH have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATAI has higher volatility (15.38%) compared to DCTH (10.97%). In terms of maximum drawdown, ATAI dropped -94.77% vs DCTH's -99.96%.
ATAI currently has the higher Sharpe Ratio (1.03 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATAI and DCTH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer